Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism.

Th phenotype development is controlled not only by cytokines but also by other parameters including genetic background. One site of genetic variation between murine strains that has direct impact on Th development is the expression of the IL-12 receptor. T cells from B10.D2 and BALB/c mice show distinct control of IL-12 receptor expression. When activated by Ag, B10.D2 T cells express functional IL-12 receptors and maintain IL-12 responsiveness. In contrast, under the same conditions, BALB/c T cells fail to express IL-12 receptors and become unresponsive to IL-12, precluding any Th1-inducing effects if subsequently exposed to IL-12. Previously, we identified a locus, which we termed T cell phenotype modifier 1 (Tpm1), on murine chromosome 11 that controls this differential maintenance of IL-12 responsiveness. In this study, we have produced a higher resolution map around Tpm1. We produced and analyzed a series of recombinants from a first-generation backcross that significantly narrows the genetic boundaries of Tpm1. This allowed us to exclude from consideration certain previous candidates for Tpm1, including IFN-regulatory factor-1. Also, cellular analysis of F1(B10.D2 x BALB/c) T cells demonstrates that Tpm1 exerts its effect on IL-12 receptor expression in a cell-autonomous manner, rather than through influencing the extracellular milieu. This result strongly implies that despite the proximity of our locus to the IL-13/IL-4 gene cluster, these cytokines are not candidates for Tpm1.

[1]  K. Silverman,et al.  Mouse Chromosome 11 , 1999, Mammalian Genome.

[2]  K. Murphy,et al.  T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. , 1997, Journal of immunology.

[3]  K. Murphy,et al.  Genetic control of Interleukin 12 responsiveness: implications for disease pathogenesis , 1997, Journal of Molecular Medicine.

[4]  T. Taniguchi,et al.  Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. , 1997, Immunity.

[5]  T. Mak,et al.  Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. , 1997, Immunity.

[6]  N. Schork,et al.  Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. , 1997, Immunity.

[7]  S. Constant,et al.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.

[8]  M. Daly,et al.  Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Eric S. Lander,et al.  A comprehensive genetic map of the mouse genome , 1996, Nature.

[10]  Eric S. Lander,et al.  A comprehensive genetic map of the mouse genome , 1996, Nature.

[11]  W. Dietrich,et al.  Genetic Susceptibility to Leishmania: IL-12 Responsiveness in TH1 Cell Development , 1996, Science.

[12]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[13]  D. Baker,et al.  Genetic analysis of experimental allergic encephalomyelitis in mice. , 1995, Journal of immunology.

[14]  D. Postma,et al.  Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. , 1995, The New England journal of medicine.

[15]  D. Meyers,et al.  Approaches to mapping genes for allergy and asthma. , 1995, American journal of respiratory and critical care medicine.

[16]  S. Szabo,et al.  Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. , 1995, Immunity.

[17]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[18]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[19]  Hans Clevers,et al.  An HMG-box-containing T-cell factor required for thymocyte differentiation , 1995, Nature.

[20]  R. Titus,et al.  T cell and non-T cell compartments can independently determine resistance to Leishmania major , 1995, The Journal of experimental medicine.

[21]  C. Hsieh,et al.  T cell genetic background determines default T helper phenotype development in vitro , 1995, The Journal of experimental medicine.

[22]  S. Romagnani,et al.  Regulation of the development of type 2 T-helper cells in allergy. , 1994, Current opinion in immunology.

[23]  N. Morton,et al.  Genetic analysis of atopy and asthma as quantitative traits and ordered polychotomies , 1994, Annals of human genetics.

[24]  D. Postma,et al.  Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. , 1994, Genomics.

[25]  H. Weiner,et al.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.

[26]  Eric S. Lander,et al.  A genetic map of the mouse with 4,006 simple sequence length polymorphisms , 1994, Nature Genetics.

[27]  J. D. Neely,et al.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. , 1994, Science.

[28]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[29]  R. Locksley,et al.  Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection , 1994, The Journal of experimental medicine.

[30]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Potter,et al.  GENETIC CONTROL OF LEISHMANIA MAJOR INFECTION IN CONGENIC, RECOMBINANT INBRED AND F2 POPULATIONS OF MICE , 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[32]  D. Largaespada,et al.  Structural comparison and chromosomal localization of the human and mouse IL-13 genes. , 1993, Journal of immunology.

[33]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[34]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[35]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[36]  C. Hsieh,et al.  Pathogen-induced Th1 phenotype development in CD4+ αβ-TCR transgenic T cells is macrophage dependent , 1993 .

[37]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[38]  S. Desiderio,et al.  itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Lovett,et al.  The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. , 1992, Nucleic acids research.

[40]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[41]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[43]  M. de Carli,et al.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.

[44]  R. Coffman,et al.  IL-4 induces a Th2 response in Leishmania major-infected mice. , 1992, Journal of immunology.

[45]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[46]  J. Merrill,et al.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Weinberg,et al.  Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. , 1991, Journal of immunology.

[48]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Soumitra Ghosh,et al.  Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.

[50]  M. Piccinni,et al.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Locksley,et al.  Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. , 1991, Immunology today.

[52]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[53]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[54]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[55]  P. D’Eustachio,et al.  Clustering of cytokine genes on mouse chromosome 11 , 1990, The Journal of experimental medicine.

[56]  R. Locksley,et al.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.

[57]  M. Belosevic,et al.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.

[58]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[59]  R. Coffman,et al.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens , 1988, The Journal of experimental medicine.

[60]  T. Taniguchi,et al.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements , 1988, Cell.

[61]  R. Locksley,et al.  Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. , 1987, Journal of immunology.

[62]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[63]  Howard Jg Immunological regulation and control of experimental leishmaniasis. , 1986 .

[64]  R. Locksley,et al.  Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. , 1986, Journal of immunology.

[65]  J. Howard Immunological regulation and control of experimental leishmaniasis. , 1986, International review of experimental pathology.

[66]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells. , 1984, Annual review of immunology.

[67]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells. IV. An antiidiotypic antibody predicts both antigen and I- specificity , 1983, The Journal of experimental medicine.

[68]  D. Katz,et al.  Regulation of IgE antibody production by serum molecules. II. Strain-specificity of the suppressive activity of serum from complete freund's adjuvant-immune low responder mouse donors. , 1978, Journal of immunology.

[69]  D. Katz,et al.  Regulation of IgE antibody production by serum molecules. I. Serum from complete Freund's adjuvant-immune donors suppresses irradiation-enhanced IgE production in low responder mouse strains. , 1978, Journal of immunology.

[70]  N. Vaz,et al.  Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy. , 1970, International archives of allergy and applied immunology.

[71]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an c43 T-cell-receptor transgenic system , 2022 .